Table 4. Univariate and multivariate logistic regression analysis for cardiac injury.
| Risk factor | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | ||
| Age, years | 1.117 (1.034–1.206) | 0.005 | 1.093 (1.011–1.182) | 0.025 | |
| Male gender | 2.800 (0.656–11.96) | 0.165 | |||
| Hypertension | 4.800 (1.126–20.460) | 0.034 | |||
| Diabetes | 4.514 (0.737–27.663) | 0.103 | |||
| Hyperlipemia | 4.514 (0.737–27.663) | 0.103 | |||
| Cardiovascular disease | 0.000 (0.000–0.000) | 1.000 | |||
| Chronic lung disease | 5.125 (0.417–62.926) | 0.202 | |||
| Malignancy | 7.714 (1.099–54.151) | 0.040 | |||
| Fever | 2.500 (0.490–12.763) | 0.270 | |||
| Cough | 1.250 (0.314–4.982) | 0.752 | |||
| Sputum production | 0.531 (0.062–4.556) | 0.531 | |||
| Headache | 4.514 (0.737–27.663) | 0.103 | |||
| Chest pain | 2.500 (0.248–25.153) | 0.437 | |||
| Fatigue | 12.640 (2.564–62.324) | 0.002 | |||
| Myalgia | 2.714 (0.480–15.343) | 0.259 | |||
| Severe and critical conditions | 16.100 (3.038–85.331) | 0.001 | |||
| Neutrophil count | 1.482 (1.070–2.052) | 0.018 | |||
| Lymphocyte count | 0.046 (0.005–0.383) | 0.004 | |||
| Creatinine | 1.015 (0.990–1.042) | 0.242 | |||
| Albumin | 0.650 (0.489–0.863) | 0.002 | |||
| C-reactive protein | 1.021 (1.007–1.035) | 0.003 | |||
| Increased NT-proBNP | 18.00 (3.758–86.227) | <0.001 | 10.979 (2.024–59.555) | 0.005 | |
| TSS score | 1.174 (1.027–1.343) | 0.019 | |||
| Prescription of oseltamivir | 4.000 (0.979–16.341) | 0.054 | |||
| Prescription of NSAID | 10.250 (0.584–179.932) | 0.111 | |||
| Prescription of glucocorticoids | 4.583 (1.114–18.854) | 0.035 | |||
Chronic lung disease includes chronic obstructive pulmonary disease and tuberculosis. TSS, total severity score; NSAID, nonsteroidal anti-inflammatory drug.